pubmed-article:18467316 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:18467316 | lifeskim:mentions | umls-concept:C0024501 | lld:lifeskim |
pubmed-article:18467316 | lifeskim:mentions | umls-concept:C0854776 | lld:lifeskim |
pubmed-article:18467316 | lifeskim:mentions | umls-concept:C0008838 | lld:lifeskim |
pubmed-article:18467316 | lifeskim:mentions | umls-concept:C0016360 | lld:lifeskim |
pubmed-article:18467316 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
pubmed-article:18467316 | lifeskim:mentions | umls-concept:C1517927 | lld:lifeskim |
pubmed-article:18467316 | lifeskim:mentions | umls-concept:C0045093 | lld:lifeskim |
pubmed-article:18467316 | lifeskim:mentions | umls-concept:C0205267 | lld:lifeskim |
pubmed-article:18467316 | lifeskim:mentions | umls-concept:C0282461 | lld:lifeskim |
pubmed-article:18467316 | lifeskim:mentions | umls-concept:C0205263 | lld:lifeskim |
pubmed-article:18467316 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
pubmed-article:18467316 | lifeskim:mentions | umls-concept:C0332283 | lld:lifeskim |
pubmed-article:18467316 | lifeskim:mentions | umls-concept:C0443196 | lld:lifeskim |
pubmed-article:18467316 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
pubmed-article:18467316 | pubmed:issue | 9 | lld:pubmed |
pubmed-article:18467316 | pubmed:dateCreated | 2008-8-25 | lld:pubmed |
pubmed-article:18467316 | pubmed:abstractText | The role of chemoradiation with systemic chemotherapy compared with chemotherapy alone in locally advanced pancreatic cancer (LAPC) is uncertain. | lld:pubmed |
pubmed-article:18467316 | pubmed:language | eng | lld:pubmed |
pubmed-article:18467316 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18467316 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:18467316 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18467316 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18467316 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18467316 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18467316 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:18467316 | pubmed:month | Sep | lld:pubmed |
pubmed-article:18467316 | pubmed:issn | 1569-8041 | lld:pubmed |
pubmed-article:18467316 | pubmed:author | pubmed-author:BossetJ FJF | lld:pubmed |
pubmed-article:18467316 | pubmed:author | pubmed-author:ButelJJ | lld:pubmed |
pubmed-article:18467316 | pubmed:author | pubmed-author:MariettiGG | lld:pubmed |
pubmed-article:18467316 | pubmed:author | pubmed-author:RougierPP | lld:pubmed |
pubmed-article:18467316 | pubmed:author | pubmed-author:BedenneLL | lld:pubmed |
pubmed-article:18467316 | pubmed:author | pubmed-author:ChauffertBB | lld:pubmed |
pubmed-article:18467316 | pubmed:author | pubmed-author:MornexFF | lld:pubmed |
pubmed-article:18467316 | pubmed:author | pubmed-author:MaingonPP | lld:pubmed |
pubmed-article:18467316 | pubmed:author | pubmed-author:HammenRR | lld:pubmed |
pubmed-article:18467316 | pubmed:author | pubmed-author:BouchéOO | lld:pubmed |
pubmed-article:18467316 | pubmed:author | pubmed-author:Stremsdoerfer... | lld:pubmed |
pubmed-article:18467316 | pubmed:author | pubmed-author:AparicioTT | lld:pubmed |
pubmed-article:18467316 | pubmed:author | pubmed-author:AzzedineAA | lld:pubmed |
pubmed-article:18467316 | pubmed:author | pubmed-author:MineurLL | lld:pubmed |
pubmed-article:18467316 | pubmed:author | pubmed-author:BonnetainFF | lld:pubmed |
pubmed-article:18467316 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:18467316 | pubmed:volume | 19 | lld:pubmed |
pubmed-article:18467316 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:18467316 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:18467316 | pubmed:pagination | 1592-9 | lld:pubmed |
pubmed-article:18467316 | pubmed:meshHeading | pubmed-meshheading:18467316... | lld:pubmed |
pubmed-article:18467316 | pubmed:meshHeading | pubmed-meshheading:18467316... | lld:pubmed |
pubmed-article:18467316 | pubmed:meshHeading | pubmed-meshheading:18467316... | lld:pubmed |
pubmed-article:18467316 | pubmed:meshHeading | pubmed-meshheading:18467316... | lld:pubmed |
pubmed-article:18467316 | pubmed:meshHeading | pubmed-meshheading:18467316... | lld:pubmed |
pubmed-article:18467316 | pubmed:meshHeading | pubmed-meshheading:18467316... | lld:pubmed |
pubmed-article:18467316 | pubmed:meshHeading | pubmed-meshheading:18467316... | lld:pubmed |
pubmed-article:18467316 | pubmed:meshHeading | pubmed-meshheading:18467316... | lld:pubmed |
pubmed-article:18467316 | pubmed:meshHeading | pubmed-meshheading:18467316... | lld:pubmed |
pubmed-article:18467316 | pubmed:meshHeading | pubmed-meshheading:18467316... | lld:pubmed |
pubmed-article:18467316 | pubmed:meshHeading | pubmed-meshheading:18467316... | lld:pubmed |
pubmed-article:18467316 | pubmed:meshHeading | pubmed-meshheading:18467316... | lld:pubmed |
pubmed-article:18467316 | pubmed:meshHeading | pubmed-meshheading:18467316... | lld:pubmed |
pubmed-article:18467316 | pubmed:meshHeading | pubmed-meshheading:18467316... | lld:pubmed |
pubmed-article:18467316 | pubmed:meshHeading | pubmed-meshheading:18467316... | lld:pubmed |
pubmed-article:18467316 | pubmed:meshHeading | pubmed-meshheading:18467316... | lld:pubmed |
pubmed-article:18467316 | pubmed:meshHeading | pubmed-meshheading:18467316... | lld:pubmed |
pubmed-article:18467316 | pubmed:meshHeading | pubmed-meshheading:18467316... | lld:pubmed |
pubmed-article:18467316 | pubmed:meshHeading | pubmed-meshheading:18467316... | lld:pubmed |
pubmed-article:18467316 | pubmed:meshHeading | pubmed-meshheading:18467316... | lld:pubmed |
pubmed-article:18467316 | pubmed:meshHeading | pubmed-meshheading:18467316... | lld:pubmed |
pubmed-article:18467316 | pubmed:meshHeading | pubmed-meshheading:18467316... | lld:pubmed |
pubmed-article:18467316 | pubmed:meshHeading | pubmed-meshheading:18467316... | lld:pubmed |
pubmed-article:18467316 | pubmed:meshHeading | pubmed-meshheading:18467316... | lld:pubmed |
pubmed-article:18467316 | pubmed:meshHeading | pubmed-meshheading:18467316... | lld:pubmed |
pubmed-article:18467316 | pubmed:meshHeading | pubmed-meshheading:18467316... | lld:pubmed |
pubmed-article:18467316 | pubmed:meshHeading | pubmed-meshheading:18467316... | lld:pubmed |
pubmed-article:18467316 | pubmed:meshHeading | pubmed-meshheading:18467316... | lld:pubmed |
pubmed-article:18467316 | pubmed:year | 2008 | lld:pubmed |
pubmed-article:18467316 | pubmed:articleTitle | Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD/SFRO study. | lld:pubmed |
pubmed-article:18467316 | pubmed:affiliation | Department of Oncology, Anticancer Center G.F. Leclerc, Dijon, France. | lld:pubmed |
pubmed-article:18467316 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:18467316 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:18467316 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:18467316 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:18467316 | pubmed:publicationType | Multicenter Study | lld:pubmed |
pubmed-article:18467316 | pubmed:publicationType | Clinical Trial, Phase III | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18467316 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18467316 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18467316 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18467316 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18467316 | lld:pubmed |